Aigner M - Search Results

1

Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse.

Kahlert C, Weber H, Mogler C, Bergmann F, Schirmacher P, Kenngott HG, Matterne U, Mollberg N, Rahbari NN, Hinz U, Koch M, Aigner M, Weitz J. Kahlert C, et al. Among authors: aigner m. Br J Cancer. 2009 Aug 4;101(3):457-64. doi: 10.1038/sj.bjc.6605136. Epub 2009 Jul 14. Br J Cancer. 2009. PMID: 19603023 Free PMC article.

2

Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer.

Rahbari NN, Aigner M, Thorlund K, Mollberg N, Motschall E, Jensen K, Diener MK, Büchler MW, Koch M, Weitz J. Rahbari NN, et al. Among authors: aigner m. Gastroenterology. 2010 May;138(5):1714-26. doi: 10.1053/j.gastro.2010.01.008. Epub 2010 Jan 25. Gastroenterology. 2010. PMID: 20100481

3

Expression of an ASCL2 related stem cell signature and IGF2 in colorectal cancer liver metastases with 11p15.5 gain.

Stange DE, Engel F, Longerich T, Koo BK, Koch M, Delhomme N, Aigner M, Toedt G, Schirmacher P, Lichter P, Weitz J, Radlwimmer B. Stange DE, et al. Among authors: aigner m. Gut. 2010 Sep;59(9):1236-44. doi: 10.1136/gut.2009.195701. Epub 2010 May 17. Gut. 2010. PMID: 20479215

4

Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma.

Bonertz A, Weitz J, Pietsch DH, Rahbari NN, Schlude C, Ge Y, Juenger S, Vlodavsky I, Khazaie K, Jaeger D, Reissfelder C, Antolovic D, Aigner M, Koch M, Beckhove P. Bonertz A, et al. Among authors: aigner m. J Clin Invest. 2009 Nov;119(11):3311-21. doi: 10.1172/JCI39608. Epub 2009 Oct 5. J Clin Invest. 2009. PMID: 19809157 Free PMC article.

5

A gene signature distinguishing CD133hi from CD133- colorectal cancer cells: essential role for EGR1 and downstream factors.

Ernst A, Aigner M, Nakata S, Engel F, Schlotter M, Kloor M, Brand K, Schmitt S, Steinert G, Rahbari N, Koch M, Radlwimmer B, Weitz J, Lichter P. Ernst A, et al. Among authors: aigner m. Pathology. 2011 Apr;43(3):220-7. doi: 10.1097/PAT.0b013e328344e391. Pathology. 2011. PMID: 21436631

6

Targeting of IL-2 and GM-CSF immunocytokines to a tumor vaccine leads to increased anti-tumor activity.

Fournier P, Aigner M, Schirrmacher V. Fournier P, et al. Among authors: aigner m. Int J Oncol. 2011 Jun;38(6):1719-29. doi: 10.3892/ijo.2011.976. Epub 2011 Mar 17. Int J Oncol. 2011. PMID: 21424118

7

An effective tumor vaccine optimized for costimulation via bispecific and trispecific fusion proteins.

Aigner M, Janke M, Lulei M, Beckhove P, Fournier P, Schirrmacher V. Aigner M, et al. Int J Oncol. 2008 Apr;32(4):777-89. Int J Oncol. 2008. PMID: 18360705

8

Optimization studies for the coupling of bispecific antibodies to viral anchor molecules of a tumor vaccine.

Fournier P, Aigner M, Schirrmacher V. Fournier P, et al. Among authors: aigner m. Int J Oncol. 2010 Nov;37(5):1203-17. doi: 10.3892/ijo_00000772. Int J Oncol. 2010. PMID: 20878068

9

Transcriptome analysis and cytokine profiling of naive T cells stimulated by a tumor vaccine via CD3 and CD25.

Fournier P, Aigner M, Schirrmacher V. Fournier P, et al. Among authors: aigner m. Int J Oncol. 2010 Dec;37(6):1439-52. doi: 10.3892/ijo_00000796. Int J Oncol. 2010. PMID: 21042712

10

Hyperpolarized ¹³C Spectroscopy with Simple Slice-and-Frequency-Selective Excitation.

Topping GJ, Heid I, Trajkovic-Arsic M, Kritzner L, Grashei M, Hundshammer C, Aigner M, Skinner JG, Braren R, Schilling F. Topping GJ, et al. Among authors: aigner m. Biomedicines. 2021 Jan 27;9(2):121. doi: 10.3390/biomedicines9020121. Biomedicines. 2021. PMID: 33513763 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

196 results

Search Page